Hydroxyzine Medical Valley Filmuhúðuð tafla 25 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

hydroxyzine medical valley filmuhúðuð tafla 25 mg

medical valley invest ab - hydroxyzinum hýdróklóríð - filmuhúðuð tafla - 25 mg

Atarax Mixtúra, lausn 2 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

atarax mixtúra, lausn 2 mg/ml

ucb nordic a/s - hydroxyzinum hýdróklóríð - mixtúra, lausn - 2 mg/ml

Atarax Filmuhúðuð tafla 25 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

atarax filmuhúðuð tafla 25 mg

ucb nordic a/s - hydroxyzinum hýdróklóríð - filmuhúðuð tafla - 25 mg

Hydroxyurea medac Hart hylki 500 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

hydroxyurea medac hart hylki 500 mg

medac gesellschaft für klinische spezialpräparate gmbh - hydroxycarbamidum inn - hart hylki - 500 mg

Adakveo Evrópusambandið - íslenska - EMA (European Medicines Agency)

adakveo

novartis europharm limited - crizanlizumab - blóðleysi, blóðkorn - other hematological agents - adakveo is indicated for the prevention of recurrent vaso occlusive crises (vocs) in sickle cell disease patients aged 16 years and older. it can be given as an add on therapy to hydroxyurea/hydroxycarbamide (hu/hc) or as monotherapy in patients for whom hu/hc is inappropriate or inadequate.

Jakavi Evrópusambandið - íslenska - EMA (European Medicines Agency)

jakavi

novartis europharm limited - ruxolitinib (sem fosfat) - myeloproliferative disorders; polycythemia vera; graft vs host disease - Æxlishemjandi lyf - myelofibrosis (mf)jakavi is indicated for the treatment of disease related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis. polycythaemia vera (Úsbekistan)ráðlagt er ætlað fyrir meðferð fullorðinn sjúklinga með polycythaemia vera sem eru ónæmir fyrir eða þola hýdroxýúrea. graft versus host disease (gvhd)jakavi is indicated for the treatment of patients aged 12 years and older with acute graft versus host disease or chronic graft versus host disease who have inadequate response to corticosteroids or other systemic therapies (see section 5.

Histasín Filmuhúðuð tafla 10 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

histasín filmuhúðuð tafla 10 mg

teva b.v.* - cetirizinum díhýdróklóríð - filmuhúðuð tafla - 10 mg

Esopram Filmuhúðuð tafla 10 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

esopram filmuhúðuð tafla 10 mg

teva b.v.* - escitalopramum oxalat - filmuhúðuð tafla - 10 mg

Esopram Filmuhúðuð tafla 15 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

esopram filmuhúðuð tafla 15 mg

teva b.v.* - escitalopramum oxalat - filmuhúðuð tafla - 15 mg

Esopram Filmuhúðuð tafla 20 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

esopram filmuhúðuð tafla 20 mg

teva b.v.* - escitalopramum oxalat - filmuhúðuð tafla - 20 mg